25 Oct Date October 25, 2021 Categories News Metabolic Activators Therapy Improve Liver Fat in NAFLD Patients A phase-2 human clinical study showed that patients with nonalcoholic fatty liver disease (NAFLD) experienced a significant reduct...
05 Aug Date August 5, 2021 Categories News Phase 2 human clinical trial shows that metabolic activators improve cognitive function in Parkinson’s disease patients ScandiBio Therapeutics announced Phase 2 clinical trial results from the study “Combined Metabolic Activators Improve Cognitive...
20 Jul Date July 20, 2021 Categories News Phase 2 human clinical trial shows that metabolic activators improve cognitive function in Alzheimer’s disease patients ScandiBio Therapeutics announced Phase 2 clinical trial results from the study “Combined Metabolic Activators Improves Cognitive...
29 Jun Date June 29, 2021 Categories News The results of a phase II and III clinical trials about the treatment of COVID-19 patients with CMAs have been published at Advanced Science The results of a Phase II and III studies have been published in the journal Advanced Science. COVID-19 is associated with mi...
24 Feb Date February 24, 2021 Categories News Phase 3 human clinical trial shows that metabolic activators accelerates recovery in COVID-19 patients The Swedish biotechnology company ScandiBio Therapeutics today announced results from the study “Combined Metabolic Activators A...
04 Feb Date February 4, 2021 Categories News Phase 2 human clinical trial shows that metabolic activators reduces liver fat in NAFLD patients ScandiBio Therapeutics announced results from the study “Combined Metabolic Activators Reduces Liver Fat in Nonalcoholic Fatty L...